|
I am not reading it that way
and as I said I read the full article 3 times and remain confused as it is very poorly presented.
Overall (ER+ and ER-s combined) recurrence peaked at 2 years and then the recurrence level stayed constant.
This illustrates my contention that it is best to delineate the recurrence rates of different types of breast cancer.
When separating out ER+ vs ER- the latter had two peaks and otherwise was much less likely to recur after 5 years. The former peaked at 2 years but continued to remain elevated many more years out than ER-, especially if there were a large no. of + lymph nodes. The vascular invasion part was particularly poorly worded, both in the abstract and in the article.
I have sort of given up on the article, but just posted it as many voice annoyance that there aren't better stats to give her2+ patients regarding their risk of recurrence and how it varies with time since surgery.
|